Immediate Impact

2 by Nobel laureates 2 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
2 intermediate papers

Works of Mei-Ching Liu being referenced

Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
2021
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
2010

Author Peers

Author Last Decade Papers Cites
Mei-Ching Liu 320 82 67 173 121 20 498
H. Roché 295 87 36 181 182 24 537
Fatma Paksoy Türköz 274 81 60 170 133 19 450
A.H. Honkoop 296 78 44 209 104 18 569
Shan Zheng 263 69 56 130 99 40 456
Tessa G. Steenbruggen 271 60 29 243 164 23 498
Laura Belvederesi 208 140 55 172 113 29 458
S. D. Costa 246 104 94 248 89 24 510
Véronique Mari 303 47 70 171 184 31 482
Simona Aloe 240 55 49 93 89 16 437
Reinaldo Chacón 297 59 58 150 89 24 569

All Works

Loading papers...

Rankless by CCL
2026